Frances Rylands-Monk[email protected]Clinical NewsDos and don'ts of publishing: What are the golden rules and pitfalls?Don't use boring titles and do make sure your introduction and list of key points are concise and not too general. These were among the top tips of publishing experts like Prof. Yves Menu, who spoke in a special session at the recent Ukrainian Congress of Radiology.November 1, 2023Clinical NewsRevel: Female lung screening trial shows cessation strategy worksEighteen months after the launch of France's female lung cancer trial, CASCADE, valuable lessons have been learnt about the optimum approach to screening, Prof. Marie-Pierre Revel reported on Sunday at the national radiology congress, JFR 2023.October 15, 2023Womens ImagingFrench radiology fights back against profit-driven acquisitionsThe issue of investment groups buying private practices when radiologists retire is a hot topic at the French national congress of radiology, JFR 2023. A senior French radiologist has called for the "generational transition" to be managed more effectively so younger colleagues can thrive in the future.October 12, 2023Artificial IntelligenceWhat do you really need to know about the president of JFR 2023?France's national radiology meeting, Journées Francophones de Radiologie (JFR) 2023, begins on 13 October. We speak with congress president Dr. Mark Zins about his career in radiology, his views on AI and other hot topics, and his hopes and plans for the Paris meeting. He also reveals his love of mountain treks.October 2, 2023Clinical NewsRockall: Radiomics can transform endometrial cancer outcomeNew radiological methods using other markers beyond the normal staging scan in endometrial cancer can help doctors stratify risk and manage patients better. That's the view of Prof. Andrea Rockall, clinical chair of radiology at Imperial College London.June 12, 2023Clinical NewsEuropean experts gaze into future of breast screeningDebate continues over MRI's role in breast cancer screening, and the evidence about the added value of functional screening is gaining ground for certain risk groups, according to speakers at a high-level panel discussion.June 12, 2023Artificial IntelligenceHow will AI adoption change the future role of radiographers?A substantial increase in the clinical implementation of artificial intelligence (AI) is having major impact on radiography practice, a new Swiss survey has shown. Educators must watch events closely to prepare students for the future, says radiographer Mélanie Champendal.March 27, 2023Artificial IntelligenceBank collapse increases long-term challenges facing radiology AIThe failure of Silicon Valley Bank on 10 March further exposes the vulnerability of an already fragile high-growth, early-stage industry sector. Market watchers assess the implications of the crash for artificial intelligence (AI) start-ups and the global imaging community.March 15, 2023ConferenceVirtual reality and postmortem imaging bring crime scenes 'to life'How do the Swiss use postmortem imaging? What technology being used in the courtroom? Leading expert Dr. Michael Thali, who is participating in the "Radiology of the Afterlife" course at ECR 2023, speaks about the Zurich approach and new trends in virtopsy.February 28, 2023ConferenceWill the Beast from the East return to Vienna to blight ECR 2023?Five years on from the Beast from the East that had a major impact on ECR and caused the Danube to freeze over, there are rumors circulating of the arrival of a cold snap this week. But no severe weather pattern is likely to affect the congress, say experts.February 27, 2023Page 1 of 40Next PageTop StoriesMolecular ImagingDublin team evaluates radiation dose in PSMA PET/CTReducing average injected dose and uptake time in prostate-specific membrane antigen (PSMA) PET/CT can lead to improved patient throughput, according to Irish researchers.CTBelgium moves ahead with novel radiology referral schemeCTAssessing CT image quality: Which method is best?CTCT pearls from Ireland’s top orthopedic hospitalMolecular ImagingSPECT/CT identifies prostate cancer patients with poor outcomes
